Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

109

CIRM-FUNDED CLINICAL TRIALS

Disease Areas	Investigator	Organization	Phase	Trial Status	Target Enrollment
B cell cancers Leukemia	Thomas J Kipps	University of California, San Diego	Phase 1/2	Active, not recruiting	102
B cell cancers Leukemia	Dr. David B. Miklos	Stanford University	Phase 1	Active, not recruiting	56
B cell cancers Leukemia Leukemia, Acute Myeloid (AML)	Dr. Matthew H Porteus	Stanford University	Phase 1	Recruiting	22
B cell cancers	Dr. Paul Finnegan	Angiocrine Bioscience, Inc.	Phase 3	Closed	130
Blood Cancer	Dr. Edward Kavalerchik	Angiocrine Bioscience, Inc.	Phase 1	Completed	10
Blood Cancer	Thomas J Kipps	University of California, San Diego	Phase 1	Completed	26
Blood Cancer Solid Tumors	Professor Irving L Weissman MD	Stanford University	Phase 1	Completed	88
Blood Cancer Bone Marrow Transplant and Viral Infection	Michael A. Pulsipher	Children’s Hospital of Los Angeles	Phase 1/2	Active, not recruiting	60
Blood Cancer	Dr. Edward Kavalerchik	Angiocrine Bioscience, Inc.	Phase 1/2	Completed	42
HIV-related Lymphoma HIV/AIDS	Dr Mehrdad Abedi	University of California, Davis	Phase 1/2	Active, not recruiting	11
Leukemia, Acute Myeloid (AML)	Dr. Colleen Delaney	Nohla Therapeutics Inc	Phase 2	Closed	146
Leukemia, Acute Myeloid (AML)	Mark Chao	Forty Seven Inc.	Phase 1	Closed	258
Leukemia, Acute Myeloid (AML)	Joseph Paul Woodard	Immune-Onc Therapeutics	Phase 1	Recruiting	106
Leukemia, Acute Myeloid (AML)	Elizabeth Budde	City of Hope, Beckman Research Institute	Phase 1	Launching	N/A
Leukemia, Acute Myeloid (AML)	Rochelle Emery	Senti Biosciences, Inc.	Phase 1	Launching	N/A
Multiple Myeloma	Rajesh Belani MD	Poseida Therapeutics, Inc.	Phase 1	Closed	105